Gregory Kane Friedman Friedman
M.D. Anderson Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Gregory Kane Friedman Friedman as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:35 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT07076498 · Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care RadiationM.D. Anderson Cancer Center · recruiting · Glioma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:35 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Ph1 Study of HSV G207 in Pediatric Malignant Cerebellar Tumors IND 16294 01/05/18.R01FD006368 · FDA · UNIVERSITY OF TX MD ANDERSON CAN CTR · fiscal years 2019 to 2026 · $250,000 awarded in 2026Same name and institution; not confirmed by an ID
- Targeting RNF2 to Synergize with Oncolytic Immunovirotherapy to Induce Anti-Cancer Immunity in MedulloblastomaR01NS146081 · NINDS · UNIVERSITY OF TX MD ANDERSON CAN CTR · fiscal years 2026 · $421,361 awarded in 2026Same name and institution; not confirmed by an ID
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in diffuse midline glioma (dipg).